Discovery

Labroots Hosts 12th Annual Neuroscience Online Event Scheduled on March 6, 2024

Retrieved on: 
Thursday, February 29, 2024
SVKM's NMIMS, Pennsylvania State University, Artificial intelligence, DSM-IV codes, University, Kellogg School, Behavior, Diagnosis, Health, Labroots, Associate, Gubra, Panel discussion, Bangladesh Technical Education Board, Networking hardware, Blood test, Translation, Ethics, NIH, Computer, Data collection, Aarhus University, Associate professor, Initiative, BRAIN, Dementia, Brain, Parkinson's disease, Natural language processing, University of Pennsylvania, Language, Drug discovery, BRAIN Initiative, Neurodegenerative disease, Thought, Social behavior, Heart, Translational neuroscience, Lewy body, Research, Multiple, Neural engineering, Collection, MD, Discovery, Depression, Medical imaging

YORBA LINDA, Calif., Feb. 29, 2024 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website offering premier, interactive virtual and hybrid events and webinars, today announced its free 12th annual event in the Neuroscience Virtual Event Series to be held on March 6, 2024. Marking a decade of sharing ground breaking research and scientific discovery via Labroots' immersive platform, this dynamic event continues its tradition of showcasing some of the brightest minds at the forefront of neuroscience impacting health and disease today.

Key Points: 
  • I am excited to discuss this at Labroots' 12th annual event in the Neuroscience Virtual Event Series."
  • Hosted by Labroots and produced on Chati, participants in the event can connect seamlessly across desktop and mobile devices while engaged in a one-stop educational experience.
  • Remember to use the hashtag #LRneuro to follow the conversation and connect with other members of the global Neuroscience community!
  • Follow @Neuroscience_LR on Twitter and @Neuroscience.LR on Facebook to stay up to date with the latest Trending News in Neuroscience.

The Future of Business Now Unlocked with GoDaddy Airo

Retrieved on: 
Monday, February 26, 2024
Social media, The World Today (magazine), AI, GoDaddy, Small business, Brick, Sale, Calendar, Eye, Discovery, Synthetic media, Press release, Human, Livestreaming, Pani, Online shopping

TEMPE, Ariz., Feb. 26, 2024 /PRNewswire/ -- For small businesses, every second saved and every dollar spent is the difference between surviving and thriving. GoDaddy recently found that, on average, small business owners expect to save more than $4,000 and 300 hours of work this year using generative AI. But they don't always know where to start, and only 26% reported using AI for their business. To make using generative AI fast and easy, GoDaddy launched GoDaddy Airo™, an AI-powered solution that saves small business owners precious time in establishing their online presence and helps them win new customers.

Key Points: 
  • To make using generative AI fast and easy, GoDaddy launched GoDaddy Airo™, an AI-powered solution that saves small business owners precious time in establishing their online presence and helps them win new customers.
  • *
    If someone has an inkling of an idea, GoDaddy Airo™ can recommend catchy domain names with just a description of their business.
  • Seconds after registering a domain, GoDaddy Airo™ automatically starts generating content for the business, including:
    Unique, eye-catching logo designs that can be easily customized to fit the business.
  • Watch Tomorrow's World Today on the Discovery and Science channels in late May to see GoDaddy Airo™ technology applied in small business settings.

Lakeshore Learning Store Opens in Memphis

Retrieved on: 
Friday, February 23, 2024
Education, Play, Senior, Parent, Discovery, Learning, Student, Nightclub

CARSON, Calif., Feb. 23, 2024 /PRNewswire/ -- Lakeshore, a leading developer and retailer of educational materials for teachers, children and families, is excited to announce the opening of a new retail store in Memphis (1213 Ridgeway Rd, Memphis, TN 38119).

Key Points: 
  • CARSON, Calif., Feb. 23, 2024 /PRNewswire/ -- Lakeshore, a leading developer and retailer of educational materials for teachers, children and families, is excited to announce the opening of a new retail store in Memphis (1213 Ridgeway Rd, Memphis, TN 38119).
  • "Lakeshore is thrilled to open another brick-and-mortar store in the state of Tennessee," said Joe Abbadessa, Senior Vice President of Consumer Sales Strategy at Lakeshore.
  • Passionate about creating materials that foster a lifelong love of learning, Lakeshore has had the privilege of serving the education community for almost 70 years.
  • To stay up to date with all things Lakeshore Learning, follow: @LakeshoreLearning .

Ono Enters into a Research Collaboration Agreement with InveniAI to Identify Novel Therapeutic Targets

Retrieved on: 
Wednesday, February 21, 2024
Senior, Algorithm, AI, Generative, Drug discovery, Discovery, Synthetic media, Patient, Machine learning, Research, Pharmaceutical industry

"InveniAI is thrilled to partner with Ono, a company renowned for its commitment to innovation in drug discovery and development. Our collaboration signifies the merging of our collective expertise and cutting-edge technologies aimed at expediting the identification of de-risked product opportunities," said Krishnan Nandabalan, Ph.D., President and CEO at InveniAI, LLC. "Our unwavering commitment to enhancing patient outcomes drives us to consistently integrate technological innovation into our processes. A testament to this is our recent incorporation of large language modules, and generative AI culminating in the creation of ChatAlphaMeldä---a game-changing tool designed for the seamless utilization of advanced technology tools across the organization."

Key Points: 
  • OSAKA, Japan, Feb. 20, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it has entered into a research collaboration agreement with InveniAI® LLC (Guilford, Connecticut, USA; President and CEO: Krishnan Nandabalan; "InveniAI"), to identify novel therapeutic targets by leveraging cutting-edge InveniAI's artificial intelligence (AI) and machine learning (ML).
  • Ono will conduct validation studies to confirm the hypotheses for multiple therapeutic target candidates identified based on InveniAI's drug discovery hypotheses.
  • "Through this collaboration, the efficiency of drug discovery research will be greatly improved, and we hope to provide innovative therapeutic options to patients worldwide."
  • "InveniAI is thrilled to partner with Ono, a company renowned for its commitment to innovation in drug discovery and development.

Key-Link to Showcase New, Industry-Leading Innovations at the 2024 International Builders' Show

Retrieved on: 
Tuesday, February 20, 2024
American Series, National Association, Aluminium, NAHB, Discovery, Patent, International Builders' Show, IBS

NEW HOLLAND, Pa., Feb. 20, 2024 /PRNewswire/ -- Key-Link, a leading manufacturer of aluminum railing systems for residential and commercial installations, has unveiled four of its high-quality, best-in-class product lines to be spotlighted in Las Vegas at the National Association of Home Builders (NAHB) International Builders' Show (IBS) on February 27-29, 2024. 

Key Points: 
  • Attendees can expect to see a wide variety of styles and looks to position their business a level above the competition.
  • Crafted with the signature Key-Link quality, its pre-installed brackets and snap-together panel design ensures swift installation even for a one-person crew.
  • By eliminating the interruption of posts, the American Series crossover posts ensure homeowners get the seamless look they want.
  • For more information on Key-Link's path to IBS 2024 and to learn more about Key-Link's offerings, visit keylinkonline.com .

Illuminate Announces Results of New Live Saving Thoracic Aortic Aneurysm Surveillance Program

Retrieved on: 
Tuesday, February 20, 2024
Thoracic aortic aneurysm, TAA, Vascular surgery, Discovery, Risk, Society, UC, University of California, Davis, Health, Patient, AAA, Illuminate, Leakage, Abdominal aortic aneurysm, Medical device

OVERLAND PARK, Kan., Feb. 20, 2024 /PRNewswire/ -- Softek Illuminate, Inc., provider of enterprise follow-up management and discovery software, and UC Davis Health have developed a centralized Thoracic Aortic Aneurysm (TAA) surveillance program that is saving lives. The effort has identified at-risk patients who may have been 'lost-to-follow-up' because they missed care due to numerous factors.

Key Points: 
  • OVERLAND PARK, Kan., Feb. 20, 2024 /PRNewswire/ -- Softek Illuminate, Inc. , provider of enterprise follow-up management and discovery software, and UC Davis Health have developed a centralized Thoracic Aortic Aneurysm (TAA) surveillance program that is saving lives.
  • This new program builds on the previously announced success between Illuminate and UC Davis Health with a centralized Abdominal Aortic Aneurysm (AAA) program.
  • This new TAA program will further advance efforts to make it easier for care navigators to manage vascular patients with critical follow-up care requirements.
  • Their participation can lower the barrier for implementing a comprehensive aneurysm surveillance program and ensure the following benefits are realized:
    Align follow-up care with health system care guidelines.

Alation Launches Data Culture Maturity Assessment to Measure the True Value of Data Initiatives

Retrieved on: 
Wednesday, February 14, 2024
Research, Kinross Gold, Data culture, Data, Discovery, Organization, Trust, Data management, Management

REDWOOD CITY, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Alation, Inc. , the data intelligence company , today announced the Data Culture Maturity Assessment to help organizations measure the value of their data culture.

Key Points: 
  • REDWOOD CITY, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Alation, Inc. , the data intelligence company , today announced the Data Culture Maturity Assessment to help organizations measure the value of their data culture.
  • The assessment applies the four core tenets of the Alation Data Culture Maturity Model – Data Search & Discovery , Data Governance , Data Literacy , and Data Leadership – to measure an organization’s data maturity and ability to realize business value from its data initiatives.
  • The Data Culture Maturity Assessment empowers organizations to address the elusive nature of data value and the absence of uniform metrics.
  • With the Data Culture Maturity Assessment, organizations can align data initiatives, such as self-service, data governance, and accelerating cloud migration, with business-specific goals and establish clear metrics to measure success.

Haute Residence and Acclaimed Real Estate Broker Myra Nourmand Continue Their Partnership Into Its Ninth Year

Retrieved on: 
Wednesday, February 14, 2024
L.A. Confidential, Social media, Aviva, RELO, Marketing, Woman, Real estate, Cumulus Media Networks, LOS, FOX, Partnership, Associate, HGTV, Haute Living, IDF, ABC, Neon Museum, Radio, Discovery, Rich, Israel Cancer Research Fund, Jewish National Fund, NBC, The Wall Street Journal, House, Variety, Knowledge, First lady, House & Garden, Trust, Los Angeles Business Journal, Residence, Rett syndrome, Fashion design

LOS ANGELES, Feb. 14, 2024 /PRNewswire-PRWeb/ -- Myra Nourmand specializes in marketing and selling luxury properties from Beverly Hills to Malibu. Myra is a role model for success-oriented women. Known as the First Lady of Real Estate in Beverly Hills, she is a high-end producer, having successfully listed and sold properties ranging from $1 million to $60 million. The vast majority of her clients are in the entertainment industry, and she has earned the trust and respect of some of the most high-profile clients. Her level of expertise in the luxury home market comes from her ability to match her client's needs with her knowledge of the inventory.

Key Points: 
  • Haute Residence and acclaimed real estate professional Myra Nourmand continue their successful partnership.
  • LOS ANGELES, Feb. 14, 2024 /PRNewswire-PRWeb/ -- Myra Nourmand specializes in marketing and selling luxury properties from Beverly Hills to Malibu.
  • Myra is the author of "From Homemaker to Breadwinner" part memoir and part real estate handbook for professionals.
  • Myra is a Real Estate Specialist with a reputation for excellence in Listing, Marketing, and Selling high-end properties.

Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance

Retrieved on: 
Wednesday, February 14, 2024
Biotechnology, General Health, Medical Devices, Health, Pharmaceutical, Acquisition, CRL, Drug development, Charles River Laboratories, Sale, Calendar, Discovery, CDMO, GAAP, DSA, RMS, Environment, Beauty salon

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth-quarter and full-year 2023 and provided guidance for 2024.

Key Points: 
  • Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth-quarter and full-year 2023 and provided guidance for 2024.
  • For the quarter, revenue was $1.01 billion, a decrease of 7.9% from $1.10 billion in the fourth quarter of 2022.
  • Revenue for the RMS segment was $195.8 million in the fourth quarter of 2023, a decrease of 0.2% from $196.1 million in the fourth quarter of 2022.
  • In the fourth quarter of 2023, the DSA segment’s GAAP operating margin decreased to 20.2% from 22.7% in the fourth quarter of 2022.

Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins

Retrieved on: 
Wednesday, February 14, 2024
Senior, Inflammation, Discovery, Protein engineering, Patient, Autoimmunity, Research, Ono Pharmaceutical, Pharmaceutical industry

OSAKA, Japan, Feb. 14, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it has entered into a drug discovery collaboration and option agreement with Shattuck Labs, Inc. (Austin, Texas, USA; CEO: Taylor Schreiber; "Shattuck") to generate bifunctional fusion proteins for pathways involved in autoimmune and inflammatory diseases.

Key Points: 
  • OSAKA, Japan, Feb. 14, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") today announced that it has entered into a drug discovery collaboration and option agreement with Shattuck Labs, Inc. (Austin, Texas, USA; CEO: Taylor Schreiber; "Shattuck") to generate bifunctional fusion proteins for pathways involved in autoimmune and inflammatory diseases.
  • Under the terms of the agreement, Shattuck will generate fusion proteins for certain targets using its proprietary protein engineering technology and provide Ono with drug candidates for further optimization and clinical development.
  • Ono will have an exclusive option right to develop and commercialize multiple potential drug candidates to be created through this collaboration worldwide.
  • This collaboration aligns with our strategy to unlock further value from our bifunctional fusion protein platform and scientific expertise."